These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38014753)

  • 21. Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study.
    Wang X; Suttner L; Jemielita T; Li X
    J Biopharm Stat; 2022 Jan; 32(1):170-190. PubMed ID: 34939894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporating external real-world data (RWD) in confirmatory adaptive design.
    Lin J; Lin J
    J Biopharm Stat; 2024 Mar; ():1-13. PubMed ID: 38515261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.
    Zisis K; Pavi E; Geitona M; Athanasakis K
    J Pharm Pharm Sci; 2024; 27():12302. PubMed ID: 38481726
    [No Abstract]   [Full Text] [Related]  

  • 24. Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process.
    Oehrlein EM; Schoch S; Burcu M; McBeth JF; Bright J; Pashos CL; Willke R; Love TR; Mattingly TJ; Perfetto EM;
    Value Health; 2023 Jan; 26(1):28-38. PubMed ID: 35863944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea.
    Lee H; Ahn HS; Kwon S; Kang HY; Han E
    Clin Transl Sci; 2024 Apr; 17(4):e13801. PubMed ID: 38629484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases.
    Vaghela S; Tanni KA; Banerjee G; Sikirica V
    Orphanet J Rare Dis; 2024 Mar; 19(1):117. PubMed ID: 38475874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Pharmacology Applications of Real-World Data and Real-World Evidence in Drug Development and Approval-An Industry Perspective.
    Zhu R; Vora B; Menon S; Younis I; Dwivedi G; Meng Z; Datta-Mannan A; Manchandani P; Nayak S; Tammara BK; Garhyan P; Iqbal S; Dagenais S; Chanu P; Mukherjee A; Ghobadi C;
    Clin Pharmacol Ther; 2023 Oct; 114(4):751-767. PubMed ID: 37393555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions.
    Wu J; Wang C; Toh S; Pisa FE; Bauer L
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RWD-Cockpit: Application for Quality Assessment of Real-world Data.
    Babrak LM; Smakaj E; Agac T; Asprion PM; Grimberg F; der Werf DV; van Ginkel EW; Tosoni DD; Clay I; Degen M; Brodbeck D; Natali EN; Schkommodau E; Miho E
    JMIR Form Res; 2022 Oct; 6(10):e29920. PubMed ID: 35266872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.
    Bakker E; Plueschke K; Jonker CJ; Kurz X; Starokozhko V; Mol PGM
    Clin Pharmacol Ther; 2023 Jan; 113(1):135-151. PubMed ID: 36254408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
    Kc S; Lin LW; Bayani DBS; Zemlyanska Y; Adler A; Ahn J; Chan K; Choiphel D; Genuino-Marfori AJ; Kearney B; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Akmal Shafie A; Sui B; Suwantika A; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Teerawattananon Y; Wee HL
    Int J Health Policy Manag; 2023; 12():6858. PubMed ID: 37579427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case study using RWD in the context of a pivotal trial for regulatory approval in a rare disease.
    O'Connell P; Ridolfi A; Fretault N
    J Biopharm Stat; 2023 Nov; 33(6):812-819. PubMed ID: 36710386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating large-scale propensity score performance through real-world and synthetic data experiments.
    Tian Y; Schuemie MJ; Suchard MA
    Int J Epidemiol; 2018 Dec; 47(6):2005-2014. PubMed ID: 29939268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
    Fu C; Pang H; Zhou S; Zhu J
    Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leveraging external evidence using Bayesian hierarchical model and propensity score in the presence of covariates.
    Chen X; Yao Y; Wang L; Mukhopadhyay S
    Contemp Clin Trials; 2023 Sep; 132():107301. PubMed ID: 37467950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sample size re-estimation for response-adaptive randomized clinical trials.
    Li X; Hu F
    Pharm Stat; 2022 Sep; 21(5):1058-1073. PubMed ID: 35191605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridging the divide between clinical research and clinical care in oncology: An integrated real-world evidence generation platform.
    Bourla AB; Meropol NJ
    Digit Health; 2021; 7():20552076211059975. PubMed ID: 34868623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-World Evidence: A Primer.
    Dang A
    Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.